In the meanwhile, there was a strong correlation between the expression of CMTM6 and that of CD3+ T cells, CD20+ B lymphocytes, and CD68+ macrophages in melanoma (Burr et al., 2017; Mezzadra et al., 2017). This evidence concerns the gene CMTM6 and melanoma.